Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Abbott Laboratories total Assets ($M) ($M)
Postgres DB financial_values + Form 10-K/10-Q XBRL
Latest, FY2025
86,713
Period ended Dec 31, 2025
Change on a year earlier
+6.5%
81,414 in FY2024
History
19 years
Since FY2007
Sources
15
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total Assets ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 86,713 | +6.5% | Form 10-K (filed 2026-02-20) ↗ |
| FY2024 | Dec 31, 2024 | 81,414 | +11.2% | Form 10-K (filed 2025-02-21) ↗ |
| FY2023 | Dec 31, 2023 | 73,214 | -1.6% | Form 10-K (filed 2024-02-16) ↗ |
| FY2022 | Dec 31, 2022 | 74,438 | -1.0% | Form 10-K (filed 2023-02-17) ↗ |
| FY2021 | Dec 31, 2021 | 75,196 | +3.6% | Form 10-K (filed 2022-02-18) ↗ |
| FY2020 | Dec 31, 2020 | 72,548 | +6.9% | Form 10-K (filed 2021-02-19) ↗ |
| FY2019 | Dec 31, 2019 | 67,887 | +1.1% | Form 10-K (filed 2020-02-21) ↗ |
| FY2018 | Dec 31, 2018 | 67,173 | -11.9% | Form 10-K (filed 2019-02-22) ↗ |
| FY2017 | Dec 31, 2017 | 76,250 | +44.8% | Form 10-K (filed 2018-02-16) ↗ |
| FY2016 | Dec 31, 2016 | 52,666 | +27.7% | Form 10-K (filed 2017-02-17) ↗ |
| FY2015 | Dec 31, 2015 | 41,247 | +0.1% | Form 10-K (filed 2016-02-19) ↗ |
| FY2014 | Dec 31, 2014 | 41,207 | -4.0% | Form 10-K (filed 2016-02-19) ↗ |
| FY2013 | Dec 31, 2013 | 42,937 | -36.1% | Form 10-K (filed 2016-02-19) ↗ |
| FY2012 | Dec 31, 2012 | 67,235 | +11.5% | Form 10-K (filed 2014-02-21) ↗ |
| FY2011 | Dec 31, 2011 | 60,277 | -0.5% | Form 10-K (filed 2014-02-21) ↗ |
| FY2010 | Dec 31, 2010 | 60,574 | +15.2% | Form 10-K (filed 2012-02-21) ↗ |
| FY2009 | Dec 31, 2009 | 52,582 | +24.0% | Form 10-K (filed 2012-02-21) ↗ |
| FY2008 | Dec 31, 2008 | 42,419 | +6.8% | Form 10-Q (filed 2009-08-07) ↗ |
| FY2007 | Dec 31, 2007 | 39,714 | – | Form 10-K (filed 2010-02-19) ↗ |
Breakdown
What makes up total assets ($m)
- Cash & Cash Equivalents ($M)8,522 · FY2025
- Short-Term Investments ($M)417 · FY2025
- Trade Accounts Receivable, Net ($M)7,929 · FY2025
- Total Inventories ($M)6,488 · FY2025
- Total Current Assets ($M)25,996 · FY2025
- Net Property & Equipment ($M)11,816 · FY2025
- Goodwill ($M)24,035 · FY2025
- Intangible Assets, Net of Amortization ($M)5,526 · FY2025
- Total Current Liabilities ($M)16,496 · FY2025
- Long-Term Debt ($M)9,896 · FY2025
- Total Shareholders' Investment / Equity ($M)52,130 · FY2025
Cite this data
StockData. (2026). Abbott Laboratories Total Assets ($M) ($M), annual FY2007–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/db-bs-assets
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.